USA - NASDAQ:DHCNL - US25525P3055
The current stock price of DHCNL is 17.97 USD. In the past year, price increased by 5.77%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WELL | WELLTOWER INC | 127.14 | 123.30B | ||
| VTR | VENTAS INC | 144.08 | 34.05B | ||
| OHI | OMEGA HEALTHCARE INVESTORS | 23.11 | 12.68B | ||
| DOC | HEALTHPEAK PROPERTIES INC | 87.7 | 12.19B | ||
| ARE | ALEXANDRIA REAL ESTATE EQUIT | N/A | 9.34B | ||
| CTRE | CARETRUST REIT INC | 28.77 | 7.90B | ||
| AHR | AMERICAN HEALTHCARE REIT INC | N/A | 7.75B | ||
| HR | HEALTHCARE REALTY TRUST INC | N/A | 6.19B | ||
| SBRA | SABRA HEALTH CARE REIT INC | 23.66 | 4.31B | ||
| DHCNI | DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 | N/A | 4.12B | ||
| NHI | NATL HEALTH INVESTORS INC | 25.06 | 3.56B | ||
| MPW | MEDICAL PROPERTIES TRUST INC | N/A | 2.96B |
Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. The company is headquartered in Newton, Massachusetts and currently employs 0 full-time employees. The firm is focused on owning healthcare properties located throughout the United States. The company has an approximately $7.2 billion portfolio, which includes over 367 properties in 36 states and Washington, D.C., occupied by approximately 450 tenants, and totaling approximately 8.0 million square feet of life science and medical office properties and more than 27,000 senior living units. The firm's segments include Medical Office and Life Science Portfolio and SHOP. Its Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical-related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents.
DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46
C/O The Rmr Group, Two Newton Pl., 255 Wash. St., Ste. 300
Newton MASSACHUSETTS US
Employees: 0
Phone: 16177968350
Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. The company is headquartered in Newton, Massachusetts and currently employs 0 full-time employees. The firm is focused on owning healthcare properties located throughout the United States. The company has an approximately $7.2 billion portfolio, which includes over 367 properties in 36 states and Washington, D.C., occupied by approximately 450 tenants, and totaling approximately 8.0 million square feet of life science and medical office properties and more than 27,000 senior living units. The firm's segments include Medical Office and Life Science Portfolio and SHOP. Its Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical-related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents.
The current stock price of DHCNL is 17.97 USD. The price decreased by -0.03% in the last trading session.
DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) has a dividend yield of 0.9%. The yearly dividend amount is currently 0.04.
DHCNL has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
DHCNL stock is listed on the Nasdaq exchange.
DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) currently has 0 employees.
DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) has a market capitalization of 4.34B USD. This makes DHCNL a Mid Cap stock.
ChartMill assigns a technical rating of 5 / 10 to DHCNL. When comparing the yearly performance of all stocks, DHCNL turns out to be only a medium performer in the overall market: it outperformed 61.64% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to DHCNL. While DHCNL seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months DHCNL reported a non-GAAP Earnings per Share(EPS) of -0.65. The EPS increased by 41.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.03% | ||
| ROE | -15.46% | ||
| Debt/Equity | 1.42 |
10 analysts have analysed DHCNL and the average price target is 18.55 USD. This implies a price increase of 3.2% is expected in the next year compared to the current price of 17.97.
For the next year, analysts expect an EPS growth of 20.64% and a revenue growth 3.66% for DHCNL